Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion type Assertion NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_head.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion description "[Clinically, pegylated-liposomal doxorubicin induced regression of not only KS, but also lymphadenopathy of the MCD lesion with a decrease in KSHV load and human interleukin-6 in the blood.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_provenance.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion evidence source_evidence_literature NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_provenance.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion SIO_000772 16984619 NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_provenance.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion wasDerivedFrom befree-20150227 NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_provenance.
- NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_assertion wasGeneratedBy ECO_0000203 NP499628.RAcXQLG9KG1hybEVItUPsMO5m9FzD5ONqW8XMpbZd9hpE130_provenance.